▩ ID9606/2a-c: Dispositive eines Virus
◈ Gilead bets $11 billion on hepatitis in Pharmasset deal

Type: Newspaper Article

Identifier:
P58K5S32
Description

Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the next generation of hepatitis C treatments.
Related people

Krauskopf, Lewis (creator)
Basu, Anand (creator)